Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$185,688
-$367,559 QoQ
Shares Held
10,339
-74.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#155
of 207 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Derivatives in AMLX

reported options exposure · as of Jun 30, 2026
CallValue
$7,279,188
CallShares
405,300
PutValue
$578,312
PutShares
32,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names. AMLX ranks #38 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,504,358 $108,103,165
2 UTHR
UNITED THERAPEUTICS Corp
 88,579 $47,994,759
3 LQDA
Liquidia Corp
 471,067 $37,558,171
4 BCRX
Biocryst Pharmaceuticals Inc
 1,195,651 $11,956,510
5 PRGO
PERRIGO Co plc
 1,149,496 $11,943,263
6 HROW
Harrow, Inc.
 190,116 $8,074,226
7 VTRS
Viatris Inc
 295,261 $4,688,744
8 TLRY
Tilray Brands, Inc.
 1,021,777 $4,587,778

All Filings in AMLX

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,279,188 405,300
2026-06-30 $185,688 10,339
2026-06-30 $578,312 32,200
2026-03-31 $553,247 39,802
2026-03-31 $3,529,210 253,900
2026-03-31 $838,170 60,300
2025-12-31 $262,136 21,700
2025-12-31 $1,308,264 108,300
2025-12-31 $832,215 68,892
2025-09-30 $2,669,076 196,400
2025-09-30 $1,375,308 101,200
2025-06-30 $710,522 110,846
2025-06-30 $912,784 142,400
2025-06-30 $85,894 13,400
2025-03-31 $337,716 95,400
2025-03-31 $5,207,074 1,470,925
2025-03-31 $128,148 36,200
2024-12-31 $3,282,483 868,382
2024-12-31 $215,460 57,000
2024-12-31 $868,266 229,700
2024-09-30 $305,856 94,400
2024-09-30 $1,029,672 317,800
2024-09-30 $1,315,948 406,157
2024-06-30 $193,040 101,600
2024-06-30 $428,070 225,300
2024-06-30 $847,472 446,038
2024-03-31 $1,372,004 483,100
2024-03-31 $700,909 246,799
2024-03-31 $2,128,864 749,600
2023-12-31 $8,286,476 562,940
2023-12-31 $2,291,904 155,700
2023-12-31 $5,096,064 346,200
2023-09-30 $3,968,765 216,754
2023-09-30 $3,286,645 179,500
2023-09-30 $4,341,301 237,100
2023-06-30 $9,480,015 439,500
2023-06-30 $1,824,822 84,600
2023-06-30 $496,174 23,003
2023-03-31 $14,523,300 495,000
2023-03-31 $898,097 30,610
2023-03-31 $3,039,624 103,600
2022-12-31 $1,348,675 36,500
2022-12-31 $9,207,940 249,200
2022-09-30 $289,522 10,285
2022-09-30 $10,077,700 358,000
2022-09-30 $26,418,775 938,500
2022-06-30 $2,662,290 138,229
2022-06-30 $2,833,146 147,100
2022-06-30 $2,074,302 107,700
2022-03-31 $598,360 46,565